Having trouble viewing this email? Click here

Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
FDA APPROVALS FDA approves extended-release, single-entity hydrocodone product with abuse-deterrent properties FDA NEWS FDA Delays Final Rule on Allowing Generic Drug Makers to Update Labels	SUMMARY OF TOP ARTICLES - NOVEMBER 26, 2014 This week's RxWire distribution comes to you early due to the Thanksgiving holiday. We wish you all a very Happy Thanksgiving! Hep C wars heat up as AbbVie scores likely EU approval for Harvoni challenger BioPharma Dive - November 24, 2014 The European Medicines Agency (EMA) has recommended approval of AbbVie's new hep C three-in-one cocktail. Sticker Shock: Some Medicare Part D Beneficiaries Will Pay More Next Year Wall Street Journal - November 19, 2014 As the new year approaches, many Americans with prescription drug coverage provided by Medicare Part D may encounter sticker shock. Breakthrough discovery contributes to future treatment of multiple sclerosis, autoimmune inflammation ScienceDaily - November 24, 2014 An avenue for therapeutic intervention of multiple sclerosis may be ahead, thanks to new research. A team found that a new type of immune T helper cells named TH-GM cells play a crucial role in the immune system and pathogenesis of neuronal inflammation. Republicans file long-awaited lawsuit challenging ACA Healthcare Dive - November 24, 2014 House Republicans have filed a long-expected lawsuit challenging the implementation of the ACA. Hospitals and pharmacies grapple with rising drug prices St. Louis Post-Dispatch - November 23, 2014 Fed up with the rising price of drugs, Ascension Health last month did something unusual. It publicly banned a drug company’s sales reps. Why there's no easy way to get patients to take their meds Healthcare Dive - November 24, 2014 People who are prescribed self-administered medications typically take only about half their prescribed doses, in spite of enormous efforts to get them to do so, according to new research published in The Cochrane Library. We Must Protect Vital '340B' Drug Discounts for Safety Net Hospitals Huffington Post - November 21, 2014 Millions of Americans receive help every year from a federal program they have never heard of: the 340B drug discount program, which allows public and nonprofit safety-net hospitals to better provide both affordable medications and vital services to the underserved. Some Painkillers Tied to Bleeding Risk in Those With Abnormal Heartbeat HealthDay News - November 17, 2014 People with atrial fibrillation should consider alternatives to commonly used NSAIDs, experts say Laws Spreading That Allow Terminal Patients Access To Experimental Drugs Kaiser Health News - November 18, 2014 Earlier this month, Arizona voters approved a referendum that allows terminally ill patients to receive experimental drugs and devices. It’s the fifth state to approve a “right-to-try” law this year. Beta-Blockers Show No Survival Benefits After Heart Attack Drug Discovery & Development - November 21, 2014 Beta-blockers offer no survival advantages to patients, post-heart attack, but they do improve survival among some heart failure patients. Cost of Diabetes Care Keeps Climbing, Report Shows HealthDay News - November 20, 2014 The cost of diabetes care in the United States has increased 48 percent in recent years, climbing to more than $322 billion annually, a new report shows. Contact, Jan Tankersley Senior Vice President, Marketing & Sales Pharmaceutical Strategies Group (PSG) Office: 972-943-7141 Email: JTankersley@PSGConsults.com PSGNewsletter@PSGConsults.com www.PSGConsults.com